Mr. Yao An | Thrombosis | Best Researcher Award
Mr. Yao An, Harbin Medical University, China
Mr. Yao An is a Ph.D. candidate at Harbin Medical University, China, specializing in thrombosis and hemostasis. His research explores ferroptosis-induced thrombotic cascades, linking oxidative stress and cellular iron overload to vascular occlusion. By identifying key biomarkers and therapeutic targets, his work advances precision medicine and anti-thrombotic drug development. With a strong academic foundation from Inner Mongolia Minzu University (B.S.) and Harbin Medical University (M.S.), he is committed to revolutionizing cardiovascular health and reducing global mortality. His contributions bridge molecular mechanisms with clinical applications, shaping the future of hematology and vascular medicine.
AUTHOR PROFILE
🎓EARLY ACADEMIC PURSUITS:
Mr. Yao An began his academic journey with a Bachelor of Science (B.S.) degree from Inner Mongolia Minzu University (2016-2020), China. His strong foundation in medical sciences and passion for research led him to pursue a Master of Science (M.S.) at Harbin Medical University (2020-2023). Driven by his quest for excellence, he is currently a Ph.D. candidate (2023-present) at the Department of Medical Laboratory Science and Technology, Harbin Medical University-Daqing.
🔬PROFESSIONAL ENDEAVORS:
Mr. Yao An is an emerging scholar in the field of thrombosis and hemostasis, with a strong focus on understanding the molecular mechanisms behind blood clot formation. His research expertise spans oxidative stress, ferroptosis, and vascular diseases, contributing to the advancement of precision medicine and targeted therapies.
🏥CONTRIBUTIONS AND RESEARCH FOCUS ON THROMBOSIS:
A central theme of Mr. Yao An’s research is ferroptosis-induced thrombotic cascades, where he explores how oxidative stress pathways contribute to vascular occlusion. His pioneering work has:
Identified key biomarkers linking cellular iron overload to thrombus formation.
Offered novel therapeutic targets for precision anti-thrombotic treatments.
Provided a molecular framework for understanding how ferroptosis disrupts hemostasis.
🌍IMPACT AND INFLUENCE:
His cutting-edge findings have significant implications for global cardiovascular health, paving the way for:
Early and precise diagnosis of thrombotic disorders.
Development of next-generation anti-thrombotic drugs.
Potential reduction in global cardiovascular mortality rates.
🏅ACADEMIC CITES AND RECOGNITION:
Mr. Yao An’s work has been widely recognized and cited in prestigious medical journals. His research not only contributes to the scientific community but also inspires future researchers in the field of cardiovascular medicine.
🚀LEGACY AND FUTURE CONTRIBUTIONS:
With an unwavering commitment to medical research, Mr. Yao An aims to:
Expand his research into novel anti-thrombotic therapies.
Strengthen collaborations with global medical institutions.
Innovate new biomarker-based diagnostic tools for early thrombosis detection.
His dedication to scientific excellence is set to revolutionize hematology and vascular medicine, leaving an indelible mark on the future of thrombosis and hemostasis research.
🌏CONCLUSION:
Mr. Yao An is a rising star in thrombosis and hemostasis research. His groundbreaking work on ferroptosis-induced thrombotic cascades bridges molecular mechanisms with clinical practice, offering new insights into vascular diseases. By identifying key biomarkers and therapeutic targets, his research paves the way for precision medicine and next-generation anti-thrombotic drugs. With a strong academic background and a passion for innovation, he is poised to make a lasting impact on global cardiovascular health . His dedication to scientific excellence will continue shaping the future of hematology and vascular medicine.
TOP NOTABLE PUBLICATIONS:
Title: Pan-Cancer Analysis of ANO6 and Experimental Validation in Metastatic Melanoma
Authors: Yao An, Haoran Dong, Meishan Yan, Quanzhi Zhang, Chunyan Gao
Journal: Biochemical Genetics
Year: 2025
Title: Erythrophagocytosis-Induced Ferroptosis Contributes to Pulmonary Microvascular Thrombosis and Thrombotic Vascular Remodeling in Pulmonary Arterial Hypertension
Authors: Yao An
Journal: Journal of Thrombosis and Haemostasis
Year: 2025
Title: OxLDL Enhances Procoagulant Activity of Endothelial Cells by TMEM16F-Mediated Phosphatidylserine Exposure
Authors: Yao An
Journal: Cell Biology International
Year: 2024
Title: Ferroptosis of Endothelial Cells Triggered by Erythrophagocytosis Contributes to Thrombogenesis in Uremia
Authors: Yao An
Journal: Thrombosis and Haemostasis
Year: 2022
Title: TMEM16F-Mediated Phosphatidylserine Exposure and Microparticle Release on Erythrocytes Contribute to Hypercoagulable State in Hyperuricemia
Authors: Yao An
Journal: Blood Cells, Molecules, and Diseases
Year: 2022
Title: Hyperuricemia Enhances Procoagulant Activity of Vascular Endothelial Cells Through TMEM16F-Regulated Phosphatidylserine Exposure and Microparticle Release
Authors: Yao An
Journal: FASEB Journal
Year: 2021